User login
It is estimated that 250,000 to 600,000 patients are diagnosed and hospitalized annually with venous thromboembolism (VTE), the third most common cardiovascular illness after acute coronary syndrome and stroke. An estimated 300,000 VTE-related deaths occur in the U.S. each year, which exceeds the total number of deaths from breast cancer, prostate cancer, AIDS, and traffic accidents combined.
Communication among care providers is an essential part of medical care; it influences patients’ quality of life and effective disease treatment. Hospitalists educate both patients and providers regarding appropriate steps to take to improve care transitions and reduce any associated risks.
To ensure hospitalists have the latest information about diagnosis, treatment, and transition of inpatients with VTE, SHM is developing:
- An online tool kit, including a literature review; implementation guide; and other references, materials, and tools (e.g., discharge instructions and checklists)
- A webinar series with free CME
To be notified when SHM’s VTE resources become available, visit www.hospitalmedicine.org/VTEtreatment.
It is estimated that 250,000 to 600,000 patients are diagnosed and hospitalized annually with venous thromboembolism (VTE), the third most common cardiovascular illness after acute coronary syndrome and stroke. An estimated 300,000 VTE-related deaths occur in the U.S. each year, which exceeds the total number of deaths from breast cancer, prostate cancer, AIDS, and traffic accidents combined.
Communication among care providers is an essential part of medical care; it influences patients’ quality of life and effective disease treatment. Hospitalists educate both patients and providers regarding appropriate steps to take to improve care transitions and reduce any associated risks.
To ensure hospitalists have the latest information about diagnosis, treatment, and transition of inpatients with VTE, SHM is developing:
- An online tool kit, including a literature review; implementation guide; and other references, materials, and tools (e.g., discharge instructions and checklists)
- A webinar series with free CME
To be notified when SHM’s VTE resources become available, visit www.hospitalmedicine.org/VTEtreatment.
It is estimated that 250,000 to 600,000 patients are diagnosed and hospitalized annually with venous thromboembolism (VTE), the third most common cardiovascular illness after acute coronary syndrome and stroke. An estimated 300,000 VTE-related deaths occur in the U.S. each year, which exceeds the total number of deaths from breast cancer, prostate cancer, AIDS, and traffic accidents combined.
Communication among care providers is an essential part of medical care; it influences patients’ quality of life and effective disease treatment. Hospitalists educate both patients and providers regarding appropriate steps to take to improve care transitions and reduce any associated risks.
To ensure hospitalists have the latest information about diagnosis, treatment, and transition of inpatients with VTE, SHM is developing:
- An online tool kit, including a literature review; implementation guide; and other references, materials, and tools (e.g., discharge instructions and checklists)
- A webinar series with free CME
To be notified when SHM’s VTE resources become available, visit www.hospitalmedicine.org/VTEtreatment.
